Thu, May 16, 2024

Liisa Bayko Maintained (ANTX) at Hold with Decreased Target to $2 on, May 16th, 2024

Liisa Bayko of Evercore ISI Group, Maintained "AN2 Therapeutics, Inc." (ANTX) at Hold with Decreased Target from $7 to $2 on, May 16th, 2024.

Liisa has made no other calls on ANTX in the last 4 months.



There are 3 other peers that have a rating on ANTX. Out of the 3 peers that are also analyzing ANTX, 2 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Jones of "Oppenheimer" Reiterated at Hold on, Monday, April 1st, 2024
  • Joseph Schwartz of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $7 on, Tuesday, February 13th, 2024


This is the rating of the analyst that currently disagrees with Liisa


  • Roy Buchanan of "JMP Securities" Upgraded from Hold to Buy and Held Target at $6 on, Tuesday, April 2nd, 2024